These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3291251)

  • 41. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of cyclosporine immunosuppression in humans.
    Kerman RH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
    [No Abstract]   [Full Text] [Related]  

  • 43. The influence of HLA-A,B and -DR matching on leucocyte infiltration in renal allografts.
    McWhinnie DL; Fuggle SV; Thompson JF; Wood RF; Morris PJ
    Tissue Antigens; 1987 Apr; 29(4):214-23. PubMed ID: 3303439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

  • 45. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 47. Significance of the donor age effect on kidney transplants.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-DR1 recipients have the highest kidney transplant survival.
    Cook DJ; Cecka JM; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
    [No Abstract]   [Full Text] [Related]  

  • 49. Pediatric cadaveric kidneys in recipients treated with cyclosporine.
    Smith AY; Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):215-21. PubMed ID: 3291246
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of HLA matching in renal transplantation.
    Ting A; Morris PJ
    Tissue Antigens; 1985 May; 25(5):225-34. PubMed ID: 3895565
    [No Abstract]   [Full Text] [Related]  

  • 51. Collaborative scheme for tissue typing and matching in renal transplantation, XI. Role of HLA-A, B, DR, and D matching and other factors on 899 cadaver kidney grafts.
    Festenstein H; Sachs JA; Butterfield K; Yeatman N; Holmes J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):934-7. PubMed ID: 7022964
    [No Abstract]   [Full Text] [Related]  

  • 52. Early rejection: determining the fate of renal transplants.
    Cecka JM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1263-4. PubMed ID: 1989207
    [No Abstract]   [Full Text] [Related]  

  • 53. Factors influencing effect of HLA matching on cadaver kidney transplants.
    Opelz G; Terasaki PI
    Transplant Proc; 1977 Dec; 9(4):1795-7. PubMed ID: 341437
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching.
    Gjertson DW; Takemoto S; Cecka JM; Terasaki PI
    Transplant Proc; 1995 Feb; 27(1):653-5. PubMed ID: 7879132
    [No Abstract]   [Full Text] [Related]  

  • 55. Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
    Weimar W; Hendriks GF; Wenting GJ; Vincent HH; Schreuder GM; Jeekel J
    Transplant Proc; 1987 Oct; 19(5):3612-3. PubMed ID: 3313869
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
    Cicciarelli J; Terasaki PI; Mickey MR
    Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved kidney graft survival through HLA-DR-MT matching.
    Müller GA; Müller C; Wernet P
    Proc Eur Dial Transplant Assoc; 1983; 19():464-8. PubMed ID: 6348746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal transplantation in Australia and New Zealand, 1963-1982: report from the ANZ Data Registry.
    Disney A
    Transplant Proc; 1984 Aug; 16(4):973-8. PubMed ID: 6380061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.